Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 201-250 of 672 result(s).
CYDY CytoDyn Inc
03/05/2021 1:24:41 PM
No just referencing NP who describe (2)
CYDY CytoDyn Inc
03/05/2021 12:30:37 PM
I hope that communication did not v (5)
CYDY CytoDyn Inc
03/04/2021 7:28:01 PM
Yes the study cited on the board wa
CYDY CytoDyn Inc
03/01/2021 4:35:11 PM
Does anyone have an opinion why the (1)
CYDY CytoDyn Inc
02/26/2021 2:31:13 PM
Sorry, although I thought people ha (2)
CYDY CytoDyn Inc
02/26/2021 2:06:31 PM
They are not scrambling: The clinic (5)
CYDY CytoDyn Inc
02/26/2021 12:31:53 PM
Exactly, IMO they are scrambling to (2)
CYDY CytoDyn Inc
02/25/2021 4:03:39 PM
Exactly they may have NOT followed
CYDY CytoDyn Inc
02/25/2021 4:01:08 PM
I agree but CYDY has no R&D.
CYDY CytoDyn Inc
02/25/2021 2:07:07 PM
I will give an example, if a patien
CYDY CytoDyn Inc
02/25/2021 2:01:59 PM
I think the data will be strong, ju
CYDY CytoDyn Inc
02/25/2021 1:44:50 PM
Just my thoughts: NP's statement of (1)
CYDY CytoDyn Inc
02/24/2021 4:45:59 PM
Depends on trial design.
CYDY CytoDyn Inc
02/23/2021 10:18:40 PM
Hopefully if all data points were f
CYDY CytoDyn Inc
02/23/2021 4:45:30 PM
Well I am not one to engage in pred
CYDY CytoDyn Inc
02/23/2021 4:08:04 PM
You are absolutely right, patients (2)
CYDY CytoDyn Inc
02/23/2021 3:26:26 PM
They never said "should" simply the (1)
CYDY CytoDyn Inc
02/23/2021 3:22:11 PM
The communication came from the FDA (3)
CYDY CytoDyn Inc
02/23/2021 3:05:13 PM
Sorry RLF changed their endpoint in
CYDY CytoDyn Inc
02/23/2021 3:00:12 PM
Those were not my words to be clear
CYDY CytoDyn Inc
02/23/2021 2:52:25 PM
My posts tend to be misunderstood: (4)
CYDY CytoDyn Inc
02/23/2021 12:50:03 PM
They changed it not for arsenic but
CYDY CytoDyn Inc
02/23/2021 11:58:51 AM
I know other companies are not to b (1)
CYDY CytoDyn Inc
02/23/2021 12:17:38 AM
he FDA just published updated guida (10)
CYDY CytoDyn Inc
02/21/2021 4:40:46 PM
That was Makary's point the recover (2)
CYDY CytoDyn Inc
02/21/2021 11:08:04 AM
https://www.wsj.com/articles/well- (2)
CYDY CytoDyn Inc
02/20/2021 1:54:04 PM
We had three concurrent trials, cou (3)
CYDY CytoDyn Inc
02/20/2021 7:46:20 AM
Great!
CYDY CytoDyn Inc
02/19/2021 3:53:53 PM
BTW if we are working on 80 indicat
CYDY CytoDyn Inc
02/19/2021 3:47:25 PM
I am sorry if it seemed rude but me (2)
CYDY CytoDyn Inc
02/19/2021 3:30:05 PM
I retired because I suffered a sub-
CYDY CytoDyn Inc
02/19/2021 1:37:09 PM
There may be a problem with the FP, (1)
CYDY CytoDyn Inc
02/19/2021 11:27:50 AM
Does it matter, the analogy stands, (1)
CYDY CytoDyn Inc
02/19/2021 11:22:29 AM
I agree, wasn't it Jim Jones who ga (1)
CYDY CytoDyn Inc
02/16/2021 10:12:56 AM
If the assay has 90% predictive val (7)
CYDY CytoDyn Inc
02/16/2021 8:25:39 AM
Absolutely correct, also I thought (2)
CYDY CytoDyn Inc
02/16/2021 8:17:17 AM
Remember every S/C patient started (6)
CYDY CytoDyn Inc
02/15/2021 11:25:35 PM
That is why an accurate assay with (2)
CYDY CytoDyn Inc
02/15/2021 11:19:42 PM
Then did not "have to" most of us t (2)
CYDY CytoDyn Inc
02/15/2021 7:51:22 PM
Mortality was not the PE (2)
CYDY CytoDyn Inc
02/13/2021 11:01:29 PM
I can't remember which one but beca
CYDY CytoDyn Inc
02/12/2021 7:29:56 PM
One of the best mentors I had said
CYDY CytoDyn Inc
02/12/2021 5:31:57 PM
That is Dr BP’s theory I guess as (1)
CYDY CytoDyn Inc
02/12/2021 10:35:00 AM
Dr. BP also thinks there could be a
CYDY CytoDyn Inc
02/11/2021 11:50:15 AM
FDA may wish to ascertain if there
CYDY CytoDyn Inc
02/10/2021 5:45:33 PM
Day 60
CYDY CytoDyn Inc
02/08/2021 4:25:30 PM
I suggested that if a stop gap sell
CYDY CytoDyn Inc
02/08/2021 3:50:31 PM
The only problem will be if insuran (1)
CYDY CytoDyn Inc
02/05/2021 11:14:57 PM
I hate to say I am very impressed w (2)
CYDY CytoDyn Inc
02/05/2021 7:40:07 PM
His work product will be similar to (4)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Strategic Collaboration Between Warburg Pincus and Madison Realty
  • OGE Energy Corp. Delivers Strong Q3 Earnings Performance
  • Yardi's Multifamily Report Reveals Rising Vacancies and Insights
  • Unleashing New Opportunities in Crypto with BC DEFI AI
  • UCB to Present Groundbreaking Research for gMG Treatments
  • Full Circle Lithium Secures Initial FCL-X Sales with Logistics Giant
  • Dyadic International to Release Financial Results in November
  • LillyDirect Teams Up with Walmart Pharmacy for Zepbound Pick-Up
  • Mayfair Gold Files Annual Information Form for Investors
  • Ettifos Launches V2X-AIR, A Game Changer for U.S. Roads
  • Evergold Corp. Secures Funding for Upcoming Drilling Program
  • Yardi Report Shows Shift in Canadian Multifamily Market Trends
  • Verano Holdings Reports Strong Q3 2025 Financial Performance
  • Bridging the Connectivity Gap on College Campuses
  • Verisk Sees Solid Revenue Growth in Recent Financial Report
  • Criteo's Strategic Move to Luxembourg: A New Chapter Begins
  • Global Voice AI Integration: Ultravox and Voximplant Unite
  • Innovative Driving Solutions: DeepRoute.ai Fuels Smart #5 EHD
  • Projected Growth of Semiconductor Gas Abatement Systems Market
  • Criteo Welcomes Edouard Dinichert to Lead Customer Strategy
  • The Dynamic Shifts of Bitcoin: Why Musk Holds Strong
  • ITI and Adena Join Forces to Enhance Crane Training Programs
  • Pleasing International's RWA Platform Revolutionizes Gold Trading
  • Robi Gone Joins IFS as Chief Information Officer to Drive Change
  • Lemon Seed Marketing Celebrates Skagit Plumbing's Brand Transformation
  • Verisk Analytics Reports Impressive Q3 2025 Earnings Growth
  • 7-Eleven Empowers Customers to Support Pediatric Health Fund
  • Virtu Financial's Impressive Q3 Performance: Key Highlights
  • WALOVI's Strategic Entry into the Middle East Beverage Market
  • Eviden Partners with NATO for Spanish Military Communication Upgrade
  • USA Rare Earth Appoints Dr. Alex Moyes as VP of Mining
  • Exciting Developments for SATO Corporation Ahead of 2026
  • Beyond Meat Provides Updates on Exchange Offer for Notes
  • XORTX Completes Direct Offering, Gaining US$1.1 Million Funding
  • National Property REIT Corp. Achieves Notable Sale and Returns
  • XORTX Therapeutics Raises $1.1 Million for Innovative Treatments
  • Beyond Meat's Strategic Exchange Offer Results and Insights
  • OKYO Pharma’s Key Presentation: Advancing Neuropathic Pain Treatment
  • Oruka Therapeutics Unveils Investor Conference Plans for November
  • EyePoint Pharmaceuticals Prepares for Q3 Financial Results Review
  • Kamada CEO to Speak at Key Healthcare Event Soon
  • Conavi Medical's Partnership Fuels Life Sciences Innovation
  • Reeflex Solutions Expands Operations with Alberta Continuance
  • Aeluma Prepares to Share Financial Insights for Q1 FY2026
  • Grayscale Solana Trust ETF (GSOL) Seizes Market Opportunities
  • ADMA Biologics to Share Q3 Financial Insights Soon
  • Seres Therapeutics Secures Up to $3.6 Million for SER-155
  • Roadzen's $200 Million Acquisition: Transforming Commercial Insurance
  • ThreeD Capital's Strategic Partnership with HyperCycle Excites Investors
  • DeepRoute.ai Drives Innovation with smart #5 EHD Collaboration
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site